Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E V Loftus

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology and Therapeutics|July 26, 2012
Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseasesD A Katzka, E V Loftus, M Camilleri
Alimentary Pharmacology & Therapeutics|February 22, 2002
The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic reviewE V Loftus, P Schoenfeld, W J Sandborn
Alimentary Pharmacology & Therapeutics|November 3, 2010
The effects of itraconazole on inflammatory bowel disease activity in patients treated for histoplasmosisS Samuel, E V Loftus, W J Sandborn
Journal of Clinical Gastroenterology|December 1, 1994
Cytomegalovirus as an exacerbating factor in ulcerative colitisE V Loftus, G L Alexander, H A Carpenter
Gastroenterology|July 3, 1998
Association of primary sclerosing cholangitis and colorectal cancer in patients with ulcerative colitis: is it true and does it matter?W J Sandborn, E V Loftus, D A Ahlquist
Gut|January 14, 2003
Cyclosporin for refractory ulcerative colitisC G Loftus, E V Loftus, W J Sandborn
Inflammatory Bowel Diseases|August 23, 2001
Epidemiology of inflammatory bowel disease in AsiaS K Yang, E V Loftus, W J Sandborn
Mayo Clinic Proceedings|February 1, 1997
Duodenal obstruction: diagnosis by gastroduodenal manometryE V Loftus, G Farrugia, J H Donohue, et al.
Alimentary Pharmacology & Therapeutics|June 17, 2015
Systematic review: colitis associated with anti-CTLA-4 therapyA Gupta, K M De Felice, E V Loftus, et al.
Alimentary Pharmacology & Therapeutics|September 17, 2015
Letter: anti-CTLA-4-associated colitis and inflammatory bowel disease pathogenesis--authors' replyA Gupta, K M De Felice, E V Loftus, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|July 26, 2012
Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseasesD A Katzka, E V Loftus, M Camilleri
Alimentary Pharmacology & Therapeutics|February 22, 2002
The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic reviewE V Loftus, P Schoenfeld, W J Sandborn
Alimentary Pharmacology & Therapeutics|November 3, 2010
The effects of itraconazole on inflammatory bowel disease activity in patients treated for histoplasmosisS Samuel, E V Loftus, W J Sandborn
Journal of Clinical Gastroenterology|December 1, 1994
Cytomegalovirus as an exacerbating factor in ulcerative colitisE V Loftus, G L Alexander, H A Carpenter
Gastroenterology|July 3, 1998
Association of primary sclerosing cholangitis and colorectal cancer in patients with ulcerative colitis: is it true and does it matter?W J Sandborn, E V Loftus, D A Ahlquist
Gut|January 14, 2003
Cyclosporin for refractory ulcerative colitisC G Loftus, E V Loftus, W J Sandborn
Inflammatory Bowel Diseases|August 23, 2001
Epidemiology of inflammatory bowel disease in AsiaS K Yang, E V Loftus, W J Sandborn
Mayo Clinic Proceedings|February 1, 1997
Duodenal obstruction: diagnosis by gastroduodenal manometryE V Loftus, G Farrugia, J H Donohue, et al.
Alimentary Pharmacology & Therapeutics|June 17, 2015
Systematic review: colitis associated with anti-CTLA-4 therapyA Gupta, K M De Felice, E V Loftus, et al.
Alimentary Pharmacology & Therapeutics|September 17, 2015
Letter: anti-CTLA-4-associated colitis and inflammatory bowel disease pathogenesis--authors' replyA Gupta, K M De Felice, E V Loftus, et al.
Pageof 8